Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernd Groner

Showing results (41-50 of 73) with videos related to

Pageof 8
Sort By:
Hormone Molecular Biology and Clinical Investigation|December 2, 2014
Transforming growth factor β signaling regulates the invasiveness of normal mammary epithelial cells and the metastasis formation of tumor cellsVida Vafaizadeh, Ulrike Graab, Tahmineh Darvishi, et al.
Hormone Molecular Biology and Clinical Investigation|December 2, 2014
Stat3 inhibition in neural lineage cellsTomohiro Chiba, Laura Mack, Natalia Delis, et al.
Endocrinology|March 24, 2011
Tracking the activation of Stat5 through the expression of an inducible reporter gene in a transgenic mouse lineNadja Lydia Bednorz, Boris Brill, Andreas Klein, et al.
Hormone Molecular Biology and Clinical Investigation|December 2, 2014
Stat3 is activated in skin lesions by the local application of imiquimod, a ligand of TLR7, and inhibited by the recombinant peptide aptamer rS3-PALaura Mack, Boris Brill, Natalia Delis, et al.
Journal of Mammary Gland Biology and Neoplasia|September 2, 2006
The biological functions of the versatile transcription factors STAT3 and STAT5 and new strategies for their targeted inhibitionSylvane Desrivières, Christian Kunz, Itamar Barash, et al.
Journal of Cancer Research and Clinical Oncology|March 20, 2012
Survivin inhibition by an interacting recombinant peptide, derived from the human ferritin heavy chain, impedes tumor cell growthAstrid Weiss, Boris Brill, Corina Borghouts, et al.
Hormone Molecular Biology and Clinical Investigation|May 12, 2015
The integration of a Stat3 specific peptide aptamer into the thioredoxin scaffold protein strongly enhances its inhibitory potencyHannah Schöneberger, Astrid Weiss, Boris Brill, et al.
Molecular Cancer Research : MCR|April 8, 2010
The intracellular delivery of a recombinant peptide derived from the acidic domain of PIAS3 inhibits STAT3 transactivation and induces tumor cell deathCorina Borghouts, Hanna Tittmann, Natalia Delis, et al.
Hormone Molecular Biology and Clinical Investigation|May 12, 2015
Visualization of Stat3 and Stat5 transactivation activity with specific response element dependent reporter constructs integrated into lentiviral gene transfer vectorsKatrin Gäbel, Nadja Lydia Bednorz, Petra Klemmt, et al.
The Journal of Biological Chemistry|November 5, 2003
The coactivator of transcription CREB-binding protein interacts preferentially with the glycosylated form of Stat5Christina Gewinner, Gerald Hart, Natasha Zachara, et al.
Pageof 8

Showing results (41-50 of 73) with videos related to

Sort By:
Pageof 8
Hormone Molecular Biology and Clinical Investigation|December 2, 2014
Transforming growth factor β signaling regulates the invasiveness of normal mammary epithelial cells and the metastasis formation of tumor cellsVida Vafaizadeh, Ulrike Graab, Tahmineh Darvishi, et al.
Hormone Molecular Biology and Clinical Investigation|December 2, 2014
Stat3 inhibition in neural lineage cellsTomohiro Chiba, Laura Mack, Natalia Delis, et al.
Endocrinology|March 24, 2011
Tracking the activation of Stat5 through the expression of an inducible reporter gene in a transgenic mouse lineNadja Lydia Bednorz, Boris Brill, Andreas Klein, et al.
Hormone Molecular Biology and Clinical Investigation|December 2, 2014
Stat3 is activated in skin lesions by the local application of imiquimod, a ligand of TLR7, and inhibited by the recombinant peptide aptamer rS3-PALaura Mack, Boris Brill, Natalia Delis, et al.
Journal of Mammary Gland Biology and Neoplasia|September 2, 2006
The biological functions of the versatile transcription factors STAT3 and STAT5 and new strategies for their targeted inhibitionSylvane Desrivières, Christian Kunz, Itamar Barash, et al.
Journal of Cancer Research and Clinical Oncology|March 20, 2012
Survivin inhibition by an interacting recombinant peptide, derived from the human ferritin heavy chain, impedes tumor cell growthAstrid Weiss, Boris Brill, Corina Borghouts, et al.
Hormone Molecular Biology and Clinical Investigation|May 12, 2015
The integration of a Stat3 specific peptide aptamer into the thioredoxin scaffold protein strongly enhances its inhibitory potencyHannah Schöneberger, Astrid Weiss, Boris Brill, et al.
Molecular Cancer Research : MCR|April 8, 2010
The intracellular delivery of a recombinant peptide derived from the acidic domain of PIAS3 inhibits STAT3 transactivation and induces tumor cell deathCorina Borghouts, Hanna Tittmann, Natalia Delis, et al.
Hormone Molecular Biology and Clinical Investigation|May 12, 2015
Visualization of Stat3 and Stat5 transactivation activity with specific response element dependent reporter constructs integrated into lentiviral gene transfer vectorsKatrin Gäbel, Nadja Lydia Bednorz, Petra Klemmt, et al.
The Journal of Biological Chemistry|November 5, 2003
The coactivator of transcription CREB-binding protein interacts preferentially with the glycosylated form of Stat5Christina Gewinner, Gerald Hart, Natasha Zachara, et al.
Pageof 8